NASDAQ
PIII
Last Price
US $10.96
Valuation
Financial
Performance
Cash flow to debt coverage
P3 Health Partners Inc. cash flow to debt ratio of -32.03% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.
Free cash flow growth
P3 Health Partners Inc.'s free cash flow has increased -17.22% from $-110.13M last year to $-91.16M, signaling increasing performance
Debt-to-equity ratio
P3 Health Partners Inc.'s debt to equity ratio is 0.44, which means that the company's assets are healthy financed, signaling financial stability.
Debt-to-equity trend
P3 Health Partners Inc.'s debt has decreased relative to shareholder equity from 2.19 last year to 0.44 today, signaling strengthened financials
Net debt to EBITDA
P3 Health Partners Inc. has negative EBITDA, making leverage ratio unreliable
Interest coverage
P3 Health Partners Inc.'s interest coverage ratio is -2.44, which means that the company struggles to meet interest obligations, signaling financial risk.
Profit margin growth
P3 Health Partners Inc.'s profit margin has increased (-27.65%) in the last year from -9.05% to -6.55%, signaling increasing performance
Current ratio
P3 Health Partners Inc.'s short-term liabilities of $545.26M exceed its short-term assets of $133.08M, signaling financial risk
Return on assets
P3 Health Partners Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization
Return on equity
P3 Health Partners Inc.'s return on equity of 161.19%, is higher than 15.00%, indicating good performance
Earnings quality
P3 Health Partners Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation
Earnings stability
P3 Health Partners Inc. had positive net income in only 0 out of 5 years, indicating unstable earnings
Positive free cash flow
P3 Health Partners Inc. has negative free cash flow, indicating the company is burning cash rather than generating it
Free cash flow yield
P3 Health Partners Inc. has negative free cash flow, indicating cash burn
Earnings growth
P3 Health Partners Inc.'s yearly earnings has decreased 8.91% since last year from $-135.85M to $-147.95M, signaling decreasing performance
Revenue growth
P3 Health Partners Inc.'s yearly revenue has decreased 2.76% since last year from $1.50B to $1.46B, signaling decreasing performance
Return on invested capital
ROIC -49.23% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.
3-year revenue CAGR
P3 Health Partners Inc.'s 3-year revenue CAGR of 11.61% is positive, indicating growing revenue over the past 3 years
Revenue consistency
P3 Health Partners Inc. had revenue growth in 4 out of 5 years, indicating consistent revenue performance
Return on equity consistency
P3 Health Partners Inc. had positive ROE in only 0 out of 5 years, indicating inconsistent returns on equity
Cash Flow Valuation (DCF)
P3 Health Partners Inc. has insufficient data to evaluate this check.
Earnings yield (TTM)
P3 Health Partners Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
EBITDA Valuation
P3 Health Partners Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model
EV/EBITDA (FY)
P3 Health Partners Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable
PEG ratio (TTM/FY)
P3 Health Partners Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Price-to-book ratio (FY)
P3 Health Partners Inc. has a price-to-book ratio of 0.31x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value
Price-to-sales ratio (TTM)
P3 Health Partners Inc. has a price-to-sales ratio of 0.03x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue
Profit margin
Current Ratio
Capital Returns
160.54%
Return on equity
ROIC: -49.23%
Valuation History
-
Price to Earnings
EV/EBITDA: -1.8X
Cash flow
Profit margin
-31.18%
Cash flow
-21.30%
Fair Value
Market $10.96
—
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.